Related Experiment Video
Updated: May 10, 2026

08:37
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
Published on: April 30, 2018
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
Ari E Friedland1, Yonatan B Tzur, Kevin M Esvelt
1Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
Nature Methods
|July 3, 2013
Summary
Scientists used CRISPR-Cas9 gene editing to create targeted, heritable genetic changes in the C. elegans germ line. This provides an effective method for generating loss-of-function mutants in this model organism.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Gene editing technologies are crucial for understanding organismal function.
- Caenorhabditis elegans is a widely used model organism for genetic studies.
Purpose of the Study:
- To demonstrate the efficacy of CRISPR-Cas9 for targeted genome modification in the C. elegans germ line.
- To establish a method for generating heritable genetic alterations in C. elegans.
Main Methods:
- Utilized clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease Cas9.
- Employed single-guide RNAs expressed from a U6 small nuclear RNA promoter to target specific genomic sequences.
- Applied the system to the germ line of Caenorhabditis elegans.
Main Results:
- Successfully targeted genomic sequences in the C. elegans germ line.
- Achieved targeted and heritable genetic alterations.
- Demonstrated the generation of loss-of-function mutants.
Conclusions:
- CRISPR-Cas9 is a powerful and effective tool for genome editing in C. elegans.
- This approach offers a convenient method for creating genetic mutants in C. elegans.
- The findings facilitate further genetic research using C. elegans.
More Related Videos
Related Concept Videos
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

